Alopecia Areata Trial, Recruiting NCT07368842 Sponsor: Singapore General Hospital Condition: Alopecia Areata
Back to Alopecia Areata

Alopecia Areata Trial, Recruiting

NCT07368842
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For all participants:

  • You are between 21 and 70 years old
  • You are able to read, understand, and sign a consent form agreeing to take part

For the healthy weight group:

  • Your BMI (a measure of body weight relative to height) falls between 18.5 and 24.9, which is considered a normal, healthy weight range
  • You do not have any long-term or ongoing health conditions
  • You are not taking any regular, long-term medications

For the severe obesity group:

  • Your BMI is above 32.5, which is considered severely obese
  • You are already scheduled to have weight-loss (bariatric) surgery

Who may not be able to join:

  • You are currently pregnant
  • There are concerns that you may have difficulty following the study's rules and schedule (confirm with trial site)
  • You have ever been diagnosed with an autoimmune hair loss condition or a type of hair loss that causes permanent scarring, such as alopecia areata, discoid lupus, or lichen planopilaris

⚠️ Important: Always verify eligibility with the trial site directly before applying. This information is a simplified summary only and is not medical advice. The trial team are the only people who can confirm whether you are eligible to participate.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Hong Chang Tan, Singapore General Hospital

Phone: +65 63214658

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Singapore General Hospital
Registry
ClinicalTrials.gov
Start date
7 February 2026
Est. completion
1 February 2028

Where this trial is recruiting

🇸🇬 Singapore

Primary endpoints

Amino acid concentration

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov